Can a cancer drug's real-world performance match clinical trial results?
NCT ID NCT04458831
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study tracks adults with relapsed or refractory multiple myeloma who are already receiving isatuximab as part of their routine care. Researchers will measure how many patients respond to treatment, how long the response lasts, and how the drug affects quality of life and side effects. The goal is to see if the benefits seen in earlier trials hold up in a broader, more diverse patient population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- isatuximab (Sarclisa), often combined with pomalidomide, dexamethasone, or carfilzomib
- What this could lead to
- If the results are positive, this could confirm that isatuximab is effective and safe for treating multiple myeloma in real-world settings, beyond controlled trials.
- What could go wrong
- This is an observational study, not a controlled experiment, so it cannot prove cause and effect. Results may be influenced by patient selection and other treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Kansas City Site Number : 8400016
Kansas City, Missouri, 64114, United States
-
AZ Nikolaas - Investigational Site Number : 0560002
Sint-Niklaas, 9100, Belgium
-
Albert Schweitzer Ziekenhuis - Investigational Site Number : 5820001
Dordrecht, 3318 AT, Netherlands
-
Auxilio Mutuo Cancer Center Site Number : 8400029
San Juan, 00917, Puerto Rico
-
Azienda Ospedaliera Universitaria "Federico II"-Investigational Site Number : 3800001
Naples, 80138, Italy
-
Azienda Ospedaliera Universitaria Policlinico Umberto I - Investigational Site Number : 3800002
Rome, Roma, 00137, Italy
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia - Investigational Site Number : 3800007
Brescia, 25123, Italy
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia - Investigational Site Number : 3800009
Rome, Roma, 00133, Italy
-
CHU Poitiers - Hôpital la Milétrie - Investigational Site Number : 2500008
Poitiers, 86021, France
-
CHU Reims - Hôpital Robert Debré - Investigational Site Number : 2500010
Reims, 51092, France
-
Central Care Cancer Center Site Number : 8400006
Garden City, Missouri, 67846, United States
-
Central Care Cancer Center Site Number : 8400019
Garden City, Kansas, 67846, United States
-
Central Maine Medical Center Site Number : 8400031
Lewiston, Maine, 04240, United States
-
Centre Hospitalier Le Mans - Investigational Site Number : 2500015
Le Mans, 72037, France
-
Centre Hospitalier Metropole Savoie - Investigational Site Number : 2500006
Chambéry, 73000, France
-
Centre Hospitalier Victor Dupouy - Investigational Site Number : 2500007
Argenteuil, 95107, France
-
Charleston Hematology Oncology Associates, PA Site Number : 8400020
Charleston, South Carolina, 29414, United States
-
Clinique Louis Pasteur, Maison Médicale - Investigational Site Number : 2500012
Essey-lès-Nancy, 54270, France
-
Complejo Asistencial Universitario de Leon Altos de Nava s/n. -Investigational Site Number : 7240005
León, León, 24071, Spain
-
Complejo Hospitalario Universitario de Pontevedra - Investigational Site Number : 7240011
Pontevedra, 36001, Spain
-
Comprehensive Hematology Oncology Site Number : 8400026
St. Petersburg, Florida, 33709, United States
-
Dietrich-Bonhoeffer-Klinikum - Investigational Site Number : 2760044
Neubrandenburg, 17036, Germany
-
Freeman Hospital - Investigational Site Number : 8260003
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
GEFOS Gesellschaft f. onkologische Studien -Investigational Site Number : 2760001
Dortmund, 44263, Germany
-
GenesisCare Site Number : 8400007
Jacksonville, Florida, 32204, United States
-
Hematology & Oncology Associates Site Number : 8400015
Canton, Ohio, 44708, United States
-
Holy Cross Hospital Site Number : 8400030
Fort Lauderdale, Florida, 33308, United States
-
Hospital Regional Universitario de Malaga Hospital Regional Universitario de Malaga - Investigational Site Number : 7240006
Málaga, Málaga, 29010, Spain
-
Hospital Universitari Son Espases - Investigational Site Number : 7240003
Palma de Mallorca, Balearic Islands, 07120, Spain
-
Hospital Universitario Virgen de la Nieves - Investigational Site Number : 7240010
Granada, 18012, Spain
-
Hospital Universitario de Navarra - Investigational Site Number : 7240009
Pamplona, Navarre, 31008, Spain
-
Huddersfield Royal Infirmary - Investigational Site Number : 8260004
Huddersfield, HD3 3EA, United Kingdom
-
Institut Jules Bordet - Investigational Site Number : 0560001
Anderlecht, 1070, Belgium
-
Investigational Site Number : 0320001
Ciudad Autonoma Buenos Aires, Buenos Aires, 1199, Argentina
-
Investigational Site Number : 0320002
Córdoba, X5016KEH, Argentina
-
Investigational Site Number : 0320004
Buenos Aires, C1118AAT, Argentina
-
Investigational Site Number : 0320005
Córdoba, X5000JHQ, Argentina
-
Investigational Site Number : 0320006
Pilar, Buenos Aires, B1629ODT, Argentina
-
Investigational Site Number : 1560001
Shenzhen, 518053, China
-
Investigational Site Number : 1560002
Guangzhou, 510120, China
-
Investigational Site Number : 1580001
Taipei, 100, Taiwan
-
Investigational Site Number : 1580002
Kaohsiung City, 833401, Taiwan
-
Investigational Site Number : 2500001
Rouen, 76038, France
-
Investigational Site Number : 2500004
Montpellier, 34295, France
-
Investigational Site Number : 2500005
Saint-Priest-en-Jarez, 42270, France
-
Investigational Site Number : 2500009
Pessac, 33604, France
-
Investigational Site Number : 2500011
Vannes, 56017, France
-
Investigational Site Number : 2500013
Lille, 59800, France
-
Investigational Site Number : 2500014
Saint-Quentin, 02321, France
-
Investigational Site Number : 2500016
Tarbes, 65013, France
-
Investigational Site Number : 2500017
Cahors, 46000, France
-
Investigational Site Number : 2760002
Dresden, 01127, Germany
-
Investigational Site Number : 2760003
Berlin, 10117, Germany
-
Investigational Site Number : 2760006
München, 81241, Germany
-
Investigational Site Number : 2760007
Donauwörth, 86609, Germany
-
Investigational Site Number : 2760008
Leipzig, 04289, Germany
-
Investigational Site Number : 2760012
Hanover, 30449, Germany
-
Investigational Site Number : 2760013
Herrsching am Ammersee, 82211, Germany
-
Investigational Site Number : 2760016
Aschaffenburg, 63739, Germany
-
Investigational Site Number : 2760018
Bayreuth, 95445, Germany
-
Investigational Site Number : 2760019
Würzburg, 97070, Germany
-
Investigational Site Number : 2760020
Bamberg, 96052, Germany
-
Investigational Site Number : 2760021
Oldenburg, 26121, Germany
-
Investigational Site Number : 2760022
Berlin, 12200, Germany
-
Investigational Site Number : 2760031
Weilheim, 82362, Germany
-
Investigational Site Number : 2760035
Dresden, 01307, Germany
-
Investigational Site Number : 2760036
Oldenburg, 26133, Germany
-
Investigational Site Number : 2760037
Frankfurt, 60596, Germany
-
Investigational Site Number : 2760040
Stolberg, 52222, Germany
-
Investigational Site Number : 2760041
Berlin, 10437, Germany
-
Investigational Site Number : 3000005
Piraeus, 18537, Greece
-
Investigational Site Number : 3440001
Hong Kong, Hong Kong
-
Investigational Site Number : 3800003
Milan, 20132, Italy
-
Investigational Site Number : 3800004
Trento, 38122, Italy
-
Investigational Site Number : 3800006
Bari, 70124, Italy
-
Investigational Site Number : 3800008
Novara, 28100, Italy
-
Investigational Site Number : 3800010
Treviso, 31100, Italy
-
Investigational Site Number : 3800013
Pavia, 27100, Italy
-
Investigational Site Number : 3920001
Yamagata, 990-9585, Japan
-
Investigational Site Number : 3920003
Sunto-gun, Shizuoka, 411-8777, Japan
-
Investigational Site Number : 3920004
Minato-ku, Tokyo, 105-8470, Japan
-
Investigational Site Number : 3920005
Okayama, 701-1192, Japan
-
Investigational Site Number : 3920008
Shibukawa-shi, 377-0280, Japan
-
Investigational Site Number : 3920009
Osaka, Osaka, 543-8555, Japan
-
Investigational Site Number : 3920010
Fukuoka, 815-8555, Japan
-
Investigational Site Number : 3920011
Suwa-shi, 392-8510, Japan
-
Investigational Site Number : 3920012
Sapporo, Hokkaido, 003-0006, Japan
-
Investigational Site Number : 3920013
Minatoku, 105-8471, Japan
-
Investigational Site Number : 3920014
Osakasayama-shi, 589-8511, Japan
-
Investigational Site Number : 4140001
Kuwait City, 42262, Kuwait
-
Investigational Site Number : 5760001
Bern, 3010, Switzerland
-
Investigational Site Number : 6430006
Volgograd, 400138, Russia
-
Investigational Site Number : 6820001
Khobar, 34234, Saudi Arabia
-
Investigational Site Number : 6820002
Riyadh, 11426, Saudi Arabia
-
Investigational Site Number : 6820004
Jeddah, 23431 6688, Saudi Arabia
-
Investigational Site Number : 6820005
Jeddah, 21423, Saudi Arabia
-
Investigational Site Number : 7240004
Toledo, 45003, Spain
-
Investigational Site Number : 7840001
Abu Dhabi, 7400, United Arab Emirates
-
Investigational Site Number : 7840002
Abu Dhabi, 11001, United Arab Emirates
-
Investigational Site Number : 8260002
Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
-
Investigational Site Number : 8260005
Sutton, Surrey, SM2 5PT, United Kingdom
-
Istituto di Ematologia e Oncologia Medica - Investigational Site Number : 3800005
Bologna, 40138, Italy
-
Kantonsspital Baden AG - Investigational Site Number : 5760003
Baden, 5404, Switzerland
-
Klinikum Ernst von Bergmann gGmbH -Investigational Site Number : 2760039
Potsdam, 14467, Germany
-
Klinikum Kulmbach mit Fachklinik Stadtsteinach - Investigational Site Number : 2760026
Kulmbach, 95326, Germany
-
Klinikum Schwaebisch Gmuend - Investigational Site Number : 2760042
Mutlangen, 73557, Germany
-
LKH Steyr - Investigational Site Number : 0400002
Steyr, 4400, Austria
-
MD Anderson Cancer Center Site Number : 8400013
Houston, Texas, 77030-4000, United States
-
MV Zentrum für Onkologie und Hämatologie - Investigational Site Number : 2760034
Cologne, 50677, Germany
-
Michigan Center of Medical Research Site Number : 8400010
Farmington Hills, Michigan, 48334, United States
-
Millennium Oncology Site Number : 8400025
Pembroke Pines, Florida, 33024, United States
-
Novant Health Forsyth Medical Center Site Number : 8400028
Winston-Salem, North Carolina, 27103, United States
-
Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus - Investigational Site Number : 2760010
Frankfurt am Main, 60389, Germany
-
Philipps-Universitat Marburg, Klinic fur Innere Medizin -Investigational Site Number : 2760038
Marburg, 35037, Germany
-
Prairie Lakes Health Care System, Inc Site Number : 8400002
Watertown, South Dakota, 57201-1548, United States
-
Praxis am Volkspark - Investigational Site Number : 2760009
Berlin, 10715, Germany
-
Prisma Health - Eastside Office Site Number : 8400011
Greenville, South Carolina, 29615, United States
-
Puerto Rico Medical Research Center, LLC Site Number : 8400001
Hato Rey, 00917, Puerto Rico
-
Regional Cancer Care Associates - Little Silver Division Site Number : 8400018
Little Silver, New Jersey, 07739, United States
-
Regional Cancer Care Associates Site Number : 8400024
Howell Township, New Jersey, 07731, United States
-
Regional Cancer Care Associates, LLC - Freehold Division Site Number : 8400017
Freehold, New Jersey, 07728, United States
-
Renovatio Clinical Site Number : 8400004
The Woodlands, Texas, 77380, United States
-
St. Joseph Heritage Healthcare Site Number : 8400008
Fullerton, California, 92835, United States
-
Stadtspital Triemli - Investigational Site Number : 5760002
Zurich, 8063, Switzerland
-
Tri County Hematology & Oncology Associates, Inc Site Number : 8400012
Massillon, Ohio, 44646, United States
-
University of Arkansas Medical Sciences Site Number : 8400021
Little Rock, Arkansas, 72205-7199, United States
-
University of California San Francisco (PARENT) Site Number : 8400009
San Francisco, California, 94143, United States
-
Watson Clinic Cancer and Research Center Site Number : 8400023
Lakeland, Florida, 33805, United States
-
omplejo Hospitalario Universitario de Canarias - Investigational Site Number : 7240007
San Cristóbal de La Laguna, 38320, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a maintenance drug keep myeloma at bay?
- New hope for frail myeloma patients: phase III trial tests smarter drug combos
- Could a tiny dose of radiation ease myeloma bone pain?
- Could a common allergy pill ease bone pain in myeloma treatment?
- New vaccine aims to train immune system against myeloma
- Multiple myeloma patients get continued access to isatuximab in safety extension study